Laxmi Organic Industries Share Price
Sector: Chemical Manufacturing
196.00 -4.70 (-2.34%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
195.30
Today’s High
201.95
52 Week Low
160.30
52 Week High
325.50
196.05 -4.48 (-2.23%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
195.37
Today’s High
202.06
52 Week Low
160.20
52 Week High
325.50
Key Metrics
- Market Cap (In Cr) 5444.06
- Beta 2
- Div. Yield (%) 0.31
- P/B 3.01
- TTM P/E 49.03
- Sector P/E 17.01
- Open Price 201.5
- Prev Close 200.7
Laxmi Organic Industries Analysis
Price Analysis
-
1 Week1.34%
-
3 Months3.88%
-
6 Month-22.14%
-
YTD-18.89%
-
1 Year-24.33%
Risk Meter
- 37% Low risk
- 37% Moderate risk
- 37% Balanced Risk
- 37% High risk
- 37% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 0.00
- 0.00
- 0.00
- 0.00
- Buy
- 1
- 1
- 1
- 1
- Hold
- 0.00
- 0.00
- 0.00
- 1
- Sell
- 2
- 2
- 2
- 1
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 3
- 3
- 3
- 3
Laxmi Organic Industries News
Stocks in focus: Rajesh Palviya of Axis Securities recommends three stocks today
3 min read . 06 Sep 2024Stocks to buy: These 12 stocks may rise 5-16% in next 2-3 weeks, say analysts
8 min read . 26 Aug 2024Laxmi Organic Industries Q1 Results Live : profit falls by 10.38% YOY
1 min read . 27 Jul 2024Laxmi Organic Industries Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 2865.01
- Selling/ General/ Admin Expenses Total
- 387.92
- Depreciation/ Amortization
- 107.61
- Other Operating Expenses Total
- -1.01
- Total Operating Expense
- 2708.8
- Operating Income
- 156.2
- Net Income Before Taxes
- 170.8
- Net Income
- 120.54
- Diluted Normalized EPS
- 4.42
- Period
- 2024
- Total Assets
- 2827.22
- Total Liabilities
- 1029.6
- Total Equity
- 1797.62
- Tangible Book Valueper Share Common Eq
- 65.14
- Period
- 2024
- Cashfrom Operating Activities
- 561.57
- Cashfrom Investing Activities
- -489.54
- Cashfrom Financing Activities
- -41.9
- Net Changein Cash
- 30.13
- Period
- 2023
- Total Revenue
- 2796.64
- Selling/ General/ Admin Expenses Total
- 381.3
- Depreciation/ Amortization
- 72.41
- Total Operating Expense
- 2611.58
- Operating Income
- 185.06
- Net Income Before Taxes
- 172.91
- Net Income
- 124.57
- Diluted Normalized EPS
- 4.64
- Period
- 2023
- Total Assets
- 2412.2
- Total Liabilities
- 1000.43
- Total Equity
- 1411.77
- Tangible Book Valueper Share Common Eq
- 53.22
- Period
- 2023
- Cashfrom Operating Activities
- 199.06
- Cashfrom Investing Activities
- -384.11
- Cashfrom Financing Activities
- 232.46
- Net Changein Cash
- 47.4
- Period
- 2022
- Total Revenue
- 3084.19
- Selling/ General/ Admin Expenses Total
- 124.44
- Depreciation/ Amortization
- 48.1
- Other Operating Expenses Total
- 479.56
- Total Operating Expense
- 2764.7
- Operating Income
- 319.49
- Net Income Before Taxes
- 318.94
- Net Income
- 257.42
- Diluted Normalized EPS
- 9.63
- Period
- 2022
- Total Assets
- 2249.46
- Total Liabilities
- 959.61
- Total Equity
- 1289.85
- Tangible Book Valueper Share Common Eq
- 48.89
- Period
- 2022
- Cashfrom Operating Activities
- 86.28
- Cashfrom Investing Activities
- 54.61
- Cashfrom Financing Activities
- -123.89
- Net Changein Cash
- 17
- Period
- 2021
- Total Revenue
- 1768.45
- Selling/ General/ Admin Expenses Total
- 239.03
- Depreciation/ Amortization
- 46.52
- Total Operating Expense
- 1589.39
- Operating Income
- 179.06
- Net Income Before Taxes
- 158.41
- Net Income
- 127.03
- Diluted Normalized EPS
- 5.6
- Period
- 2021
- Total Assets
- 1837.36
- Total Liabilities
- 802.77
- Total Equity
- 1034.59
- Tangible Book Valueper Share Common Eq
- 39.2
- Period
- 2021
- Cashfrom Operating Activities
- 106.17
- Cashfrom Investing Activities
- -641.03
- Cashfrom Financing Activities
- 527.37
- Net Changein Cash
- -7.49
- Period
- 2020
- Total Revenue
- 1534.12
- Selling/ General/ Admin Expenses Total
- 175.13
- Depreciation/ Amortization
- 48.89
- Other Operating Expenses Total
- -13.02
- Total Operating Expense
- 1436.71
- Operating Income
- 97.41
- Net Income Before Taxes
- 80.8
- Net Income
- 70.08
- Diluted Normalized EPS
- 2.66
- Period
- 2020
- Total Assets
- 1070.63
- Total Liabilities
- 643.71
- Total Equity
- 426.92
- Tangible Book Valueper Share Common Eq
- 16.16
- Period
- 2020
- Cashfrom Operating Activities
- 196
- Cashfrom Investing Activities
- -55.76
- Cashfrom Financing Activities
- -123.78
- Net Changein Cash
- 16.47
- Period
- 2019
- Total Revenue
- 1568.52
- Selling/ General/ Admin Expenses Total
- 182.56
- Depreciation/ Amortization
- 44.06
- Other Operating Expenses Total
- 6.85
- Total Operating Expense
- 1448.11
- Operating Income
- 120.41
- Net Income Before Taxes
- 97.59
- Net Income
- 72.39
- Diluted Normalized EPS
- 2.74
- Period
- 2019
- Total Assets
- 1014.49
- Total Liabilities
- 564.64
- Total Equity
- 449.84
- Tangible Book Valueper Share Common Eq
- 17.02
- Period
- 2019
- Cashfrom Operating Activities
- 187.65
- Cashfrom Investing Activities
- -122.55
- Cashfrom Financing Activities
- -62.7
- Net Changein Cash
- 2.41
- Period
- 2024-12-31
- Total Revenue
- 786.34
- Selling/ General/ Admin Expenses Total
- 34.52
- Depreciation/ Amortization
- 31.19
- Other Operating Expenses Total
- 93.6
- Total Operating Expense
- 742.76
- Operating Income
- 43.58
- Net Income Before Taxes
- 47.05
- Net Income
- 29.31
- Diluted Normalized EPS
- 1.05
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 771.25
- Selling/ General/ Admin Expenses Total
- 41.19
- Depreciation/ Amortization
- 27.46
- Other Operating Expenses Total
- 101.01
- Total Operating Expense
- 724.02
- Operating Income
- 47.23
- Net Income Before Taxes
- 46.25
- Net Income
- 28.09
- Diluted Normalized EPS
- 1
- Period
- 2024-09-30
- Total Assets
- 2827.98
- Total Liabilities
- 971.81
- Total Equity
- 1856.17
- Tangible Book Valueper Share Common Eq
- 67.07
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -29.24
- Cashfrom Investing Activities
- -77.73
- Cashfrom Financing Activities
- 40.64
- Net Changein Cash
- -66.33
- Period
- 2024-06-30
- Total Revenue
- 718.17
- Selling/ General/ Admin Expenses Total
- 38.7
- Depreciation/ Amortization
- 25.87
- Other Operating Expenses Total
- 85.58
- Total Operating Expense
- 672.84
- Operating Income
- 45.32
- Net Income Before Taxes
- 53.98
- Net Income
- 34.35
- Diluted Normalized EPS
- 1.23
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 789.23
- Selling/ General/ Admin Expenses Total
- 43
- Depreciation/ Amortization
- 30.55
- Other Operating Expenses Total
- 100.55
- Total Operating Expense
- 732.16
- Operating Income
- 57.06
- Net Income Before Taxes
- 67.99
- Net Income
- 44.3
- Diluted Normalized EPS
- 1.62
- Period
- 2024-03-31
- Total Assets
- 2827.22
- Total Liabilities
- 1029.6
- Total Equity
- 1797.62
- Tangible Book Valueper Share Common Eq
- 65.14
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 561.57
- Cashfrom Investing Activities
- -489.54
- Cashfrom Financing Activities
- -41.9
- Net Changein Cash
- 30.13
- Period
- 2023-12-31
- Total Revenue
- 694.3
- Selling/ General/ Admin Expenses Total
- 37.72
- Depreciation/ Amortization
- 27.53
- Other Operating Expenses Total
- 66.35
- Total Operating Expense
- 669.57
- Operating Income
- 24.73
- Net Income Before Taxes
- 29.55
- Net Income
- 27.19
- Diluted Normalized EPS
- 0.97
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Laxmi Organic Industries Technical
Moving Average
SMA
- 5 Day191.59
- 10 Day181.98
- 20 Day180.62
- 50 Day178.27
- 100 Day199.35
- 300 Day236.66
Laxmi Organic Industries Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Sharda Cropchem
- 617.15
- -12.65
- -2.01
- 886.35
- 345
- 5540.69
- Fischer Medical Ventures
- 838
- -19.55
- -2.28
- 919
- 513.1
- 5458.27
- Laxmi Organic Industries
- 196
- -4.7
- -2.34
- 325.5
- 160.3
- 5444.06
- Refex Industries
- 406.8
- -11.2
- -2.68
- 600
- 124.55
- 5255.14
- India Glycols
- 1729.45
- 6.75
- 0.39
- 1796.6
- 685
- 5366.63
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Sharda Cropchem
- 18.67
- 2.27
- 12.63
- 7.18
- Fischer Medical Ventures
- 519.73
- 56.56
- 4.18
- 7.82
- Laxmi Organic Industries
- 45.33
- 3.08
- 13.23
- 5.81
- Refex Industries
- 33.82
- 4.46
- 26.03
- 6.92
- India Glycols
- 31.28
- 2.59
- 10.97
- 2.6
Laxmi Organic Industries Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 20-May-25
- Audited Results & Final Dividend
- 22-Jan-25
- Quarterly Results & Others
- 29-Oct-24
- Quarterly Results
- 26-Jul-24
- Quarterly Results
- 21-May-24
- Audited Results & Dividend
- 24-Jan-24
- Quarterly Results
- 26-Oct-23
- Quarterly Results
- 28-Jul-23
- Quarterly Results
- 12-May-23
- Audited Results & Final Dividend
- 20-Apr-23
- Preferential issue of shares
- Meeting Date
- Announced on
- Purpose
- 30-Jul-24
- 09-Jul-24
- AGM
- 03-Aug-23
- 12-May-23
- AGM
- 29-Jul-22
- 04-May-22
- AGM
- 26-Jul-21
- 26-May-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 21-May-24
- 19-Jul-24
- 19-Jul-24
- 0.6
- 12-May-23
- 21-Jul-23
- 21-Jul-23
- 0.5
- 04-May-22
- 19-Jul-22
- 18-Jul-22
- 0.7
- 25-May-21
- 15-Jul-21
- 14-Jul-21
- 0.5


